FineTest
SKU(재고 관리 코드):EH3927
Human TSPAN30/CD63(Tetraspanin 30) ELISA Kit
Human TSPAN30/CD63(Tetraspanin 30) ELISA Kit
Product Name
Human TSPAN30/CD63(Tetraspanin 30) ELISA Kit
Alias
TSPAN30 ELISA Kit, CD63 ELISA Kit, Granulophysin ELISA Kit, Lamp-3 ELISA Kit, ME491 ELISA Kit, OMA81H ELISA Kit, Tspan30 ELISA Kit, CD63 antigen ELISA Kit, CD63 antigen ELISA Kit, melanoma 1 antigen ELISA Kit, CD63 molecule ELISA Kit, Granulophysin ELISA Kit, LAMP-3 ELISA Kit, Lysosomal-associated membrane protein 3 ELISA Kit, ME491 ELISA Kit, melanoma 1 antigen ELISA Kit, Melanoma-associated antigen ME491 ELISA Kit, melanoma-associated antigen MLA1 ELISA Kit, MLA1lysosome-associated membrane glycoprotein 3 ELISA Kit, Ocular melanoma-associated antigen ELISA Kit, OMA81H ELISA Kit, Tetraspanin-30 ELISA Kit, tetraspanin-30 ELISA Kit, tspan-30 ELISA Kit, Tspan-30 ELISA Kit, TSPAN30granulophysin ELISA Kit
Detection Method
Sandwich ELISA, Double Antibody
Application
TSPAN30/CD63 ELISA Kit allows for the in vitro quantitative determination of TSPAN30/CD63 concentrations in serum, plasma, tissue homogenates and other biological fluids.
Size
96T
Range
0.156-10ng/ml
Sensitivity
< 0.094ng/ml
Species
Human
UniProt ID
Standard Curve
Storage
2-8 ℃ for 6 months
Recovery
Matrices listed below were spiked with certain level of TSPAN30/CD63 and the recovery rates were calculated by comparing the measured value to the expected amount of TSPAN30/CD63 in samples.
|
Matrix |
Recovery range(%) |
Average(%) |
|
serum(n=5) |
87-103 |
95 |
|
EDTA plasma(n=5) |
85-98 |
91 |
|
heparin plasma(n=5) |
93-100 |
97 |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of TSPAN30/CD63 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
|
Sample |
1:2 |
1:4 |
1:8 |
|
serum(n=5) |
86-105% |
91-104% |
85-103% |
|
EDTA plasma(n=5) |
84-89% |
82-94% |
88-101% |
|
heparin plasma(n=5) |
91-100% |
84-100% |
84-97% |
CV(%)
Intra-Assay: CV<8%
Inter-Assay: CV<10%
Note
For Research Use Only
Share
